EUVIMEDEUVIMED entdecken
Crossref

Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics

Anna Lorenzin, Massimo de Cal, Natascha Perin, Niccolò Morisi, Alessandra Brendolan, Paolo Lentini, Monica Zanella, Claudio Ronco

Blood Purification · 2024

DOI: 10.1159/000540061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Anna Lorenzin und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy. Hauptthemen laut MEDLINE: Enkephalins, Protein Precursors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Enkephalins, endogenous opioid peptides, are involved in the regulation of renal function. One derived molecule, proenkephalin A, also known as penKid, has been demonstrated to be a reliable biomarker for kidney function and its plasma concentration correlates with measured glomerular filtration rate. penKid is used for prediction and diagnosis of AKI and need of renal replacement therapy (RRT). penKid has also been used to predict the successful weaning from RRT in patients with AKI. Whether the concentration of penKid is affected or not by RRT is a controversial point and there are no studies describing the kinetics of the molecule in such conditions. The low molecular weight (4.5 kDa) would imply free removal by the glomerulus and the dialysis membranes. During RRT, this reduction could not be detected in clinical practice due to the complex kinetics involving either low dialytic clearance or increased production in response to impaired kidney function. The aim of this study was to determine the sieving coefficient and the diffusive clearance of the penKid molecule in conditions of in vitro continuous veno-venous hemofiltration (CVVH) and continuous veno-venous hemodialysis (CVVHD), respectively, and also the penKid removal ratio in conditions of in vitro hemoadsorption (HA) using a synthetic microporous resin.

Methods

Blood spiked with a lyophilized penKid peptide solved in 20 mm dipotassium phosphate and 6 mm disodium EDTA [pH 8] to reach target concentrations is used as testing solution. In each experiment, the blood batch was adjusted at a volume of 1,000 mL, maintained at 37°, and continuously stirred. Samples were collected from blood, ultrafiltrate, and spent dialysate at different times during the experiments. Sieving, clearance, and removal ratio were calculated.

Results

Significant removal of penKid was observed in CVVH (sieving 1.04 ± 0.27), in CVVHD (clearance 23.08 ± 0.89), and in HA (removal ratio 76.1 ± 1% after 120 min). Conclusion: penKid is effectively removed by extracorporeal therapies. In presence of anuria, penKid generation kinetics can be calculated based on extracorporeal removal and volume variation. In steady state conditions, declining values may be the result of an initial renal function recovery and may suggest discontinuation and successful liberation from RRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnkephalinsProtein PrecursorsHumansKineticsHemofiltrationRenal DialysisContinuous Renal Replacement TherapyAdsorptionAcute Kidney InjuryPeptide Fragments

Stichwörter der Autor:innen

Acute kidney injuryCRRT discontinuationContinuous renal replacement therapyExtracorporeal therapies

Substanzen

EnkephalinsproenkephalinProtein PrecursorsPeptide Fragments

Autor:innen und Institutionen

  • International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy.
  • Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.
  • Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Nephrology, San Bassiano Hospital, Bassano del Grappa, Italy.

Zitieren

APA

Lorenzin, A., de Cal, M., Perin, N., Morisi, N., Brendolan, A., Lentini, P., Zanella, M., & Ronco, C. (2024). Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics. Blood Purification. https://doi.org/10.1159/000540061

Vancouver

Lorenzin A, de Cal M, Perin N, Morisi N, Brendolan A, Lentini P, et al. Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics. Blood Purification. 2024. doi:10.1159/000540061

BibTeX
@article{Lorenzin2024,
  author = {Lorenzin, Anna and de Cal, Massimo and Perin, Natascha and Morisi, Niccolò and Brendolan, Alessandra and Lentini, Paolo and Zanella, Monica and Ronco, Claudio},
  title = {Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics},
  journal = {Blood Purification},
  year = {2024},
  doi = {10.1159/000540061}
}
Kostenlos starten →